| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 06/18/2002 | US6407241 Reacting the corresponding with amine and phosgene; cyclization; therapy for bone disorders; antiinflammatory agents |
| 06/18/2002 | US6407230 Method for producing lactams using oligophosphate catalysts |
| 06/18/2002 | US6407125 Administering 2-carboxypyridine derivative to treat skin, respiratory system, and immune disorders; anticarcinogenic, antiinflammatory and antiviral agents; deactivating metal-protein complexes |
| 06/18/2002 | US6407123 Diaminopyridine-containing thiourea inhibitors of herpes viruses |
| 06/18/2002 | US6407120 Administering pyridinylacetamide or phenylacetamide derivative to treat cardiovascular, eating, sexual, brain, nervous system, gastrointestinal, urogenital, psychological, and respiratory system disorders |
| 06/18/2002 | US6407111 Phenyl substituted pyridine and benzene derivatives |
| 06/18/2002 | US6407100 Fungicidal aromatic oximes |
| 06/18/2002 | CA2059088C Pesticidal 1-(2-pyridyl)pyrazoles |
| 06/13/2002 | WO2002046249A2 Methods of copolymerizing ethylene and isobutylene and polymers made thereby |
| 06/13/2002 | WO2002046240A1 Multicomponent compositions containing chitosan and methods of preparing same |
| 06/13/2002 | WO2002046201A1 Catalyst composition and method of polymerization |
| 06/13/2002 | WO2002046194A2 Substituted imidazopyridines |
| 06/13/2002 | WO2002046162A1 Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 06/13/2002 | WO2002046161A1 Substituted carboxylic acid derivatives |
| 06/13/2002 | WO2002046160A2 Process for making a thrombin inhibitor |
| 06/13/2002 | WO2002046150A2 Compounds which mimic the chemical and biological properties of discodermolide |
| 06/13/2002 | WO2002046148A1 Substituted anthranilic acids |
| 06/13/2002 | WO2002046144A1 Tetralone derivatives as antitumor agents |
| 06/13/2002 | WO2002046142A1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides |
| 06/13/2002 | WO2002046130A1 Processes for electrically activated transformation of chemical and material compositions |
| 06/13/2002 | WO2002046129A2 Inhibitors of histone deacetylase |
| 06/13/2002 | WO2002028825A3 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |
| 06/13/2002 | WO2002008222A3 HETEROARYL-β-ALANINE DERIVATIVES AS ALPHA 4 INTEGRIN INHIBITORS |
| 06/13/2002 | WO2002004404A3 7,8 and 9-substituted tetracycline compounds |
| 06/13/2002 | WO2001083438A3 New gamma selective retinoids |
| 06/13/2002 | WO2001072309A3 Treatment of cerebrovascular disease |
| 06/13/2002 | WO2001039884A3 Chiral catalysts for asymmetric acylation and related transformations |
| 06/13/2002 | US20020072531 Useful as anticoagulants in mammals; inhibitors of factor Xa |
| 06/13/2002 | US20020072529 For therapy and prophylaxis of cerebral apoplexy and craniocerebral trauma |
| 06/13/2002 | US20020072520 For use in therapy of hyperlipidemia and arteriosclerotic disorders |
| 06/13/2002 | US20020072518 Bicyclic alphavbeta3 antagonists |
| 06/13/2002 | US20020071857 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor |
| 06/13/2002 | CA2436870A1 Substituted anthranilic acids |
| 06/13/2002 | CA2431045A1 Compounds which mimic the chemical and biological properties of discodermolide |
| 06/13/2002 | CA2431040A1 Substituted imidazopyridines |
| 06/13/2002 | CA2430846A1 Substituted carboxylic acid derivatives |
| 06/13/2002 | CA2430842A1 Process for making a thrombin inhibitor |
| 06/13/2002 | CA2430355A1 Tetralone derivatives as antitumor agents |
| 06/13/2002 | CA2429843A1 Catalyst composition and method of polymerization |
| 06/13/2002 | CA2426988A1 Multicomponent compositions containing chitosan and methods of preparing same |
| 06/12/2002 | EP1213288A1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 06/12/2002 | EP1212302A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 06/12/2002 | EP1212301A1 Arylalkyloxyalkylamines and arylalkylthioalkylamines, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors |
| 06/12/2002 | EP1212059A1 Iron chelators and uses thereof |
| 06/12/2002 | EP1056722B1 Bisulfate salt of hiv protease inhibitor |
| 06/12/2002 | EP0984778B1 Neuropeptide-y ligands |
| 06/12/2002 | EP0977484A4 Non-spherical and non-platelet pyrithione salts |
| 06/12/2002 | EP0966437B1 5-aroylnaphthalene derivatives |
| 06/12/2002 | EP0946570B1 Process for the preparation of an organozinc reagent |
| 06/12/2002 | EP0929517B1 Hydroxamic acid derivatives |
| 06/12/2002 | EP0928193B1 Use of 1-hydroxy-2-pyridones for the treatment of skin diseases |
| 06/12/2002 | EP0889879B1 Butadiene derivatives and process for preparing thereof |
| 06/12/2002 | EP0885204B1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 06/12/2002 | EP0873312B1 Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors |
| 06/12/2002 | EP0751939B1 Naphthylamides as central nervous system agents |
| 06/12/2002 | EP0652867B1 Novel pyridyl- and pyrimidylpiperazine derivatives |
| 06/12/2002 | CN1353697A 4-phenyl-pyrimidine derivatives |
| 06/12/2002 | CN1353696A 5-phenyl-pyrimidine derivatives |
| 06/12/2002 | CN1353693A Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors |
| 06/12/2002 | CN1353691A Cell adhesion-inhibiting anti inflammatory and immune-suppresive compounds |
| 06/12/2002 | CN1353690A Bradykinin receptor antagonists |
| 06/11/2002 | US6403800 Synthesis of 1-(2-sulfoethyl)-pyridinium betaine |
| 06/11/2002 | US6403644 For prevention and/or treatment of diseases induced by overexpression and excess activity of matrix metalloproteinase; for example, rheumatoid, arthrosteitis, unusual bone resorption, osteoporosis, periodontitis |
| 06/11/2002 | US6403618 Administering picolinic acid derivatives to chelate with zinc and iron in proteins; antiangiogenic and antineoplastic agent |
| 06/11/2002 | US6403617 Including human cytomegalovirus, herpes simplex viruses, epstein-barr virus, varicella-zoster virus, humanherpesviruses-6 and -7, and kaposi herpesvirus |
| 06/11/2002 | US6403607 Sulfonamide derivatives and drugs containing the same as the active ingredient |
| 06/11/2002 | US6403596 Substituted pyridones having cytokine inhibitory activity |
| 06/11/2002 | US6403589 Nucleoside transport inhibitor |
| 06/11/2002 | US6403587 Autoimmune diseases, acute and chronic inflammatory conditions, allergic conditions, infection associated with inflammation, viral, transplantation tissue rejection, atherosclerosis, restenosis, hiv infectivity, and |
| 06/11/2002 | US6403586 Interleukin inhibitors |
| 06/11/2002 | US6403585 α-and β-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 06/11/2002 | US6403583 Anticoagulant agents for treatment and prevention of thromboembolic disorders. |
| 06/11/2002 | US6403054 Ternary ligand complexes useful as radiopharmaceuticals |
| 06/11/2002 | US6402037 Two-photon upconverting dyes and applications |
| 06/11/2002 | CA2044498C Process for the preparation of dialkyl, pyridine-2,3-dicarboxylates and derivatives thereof from dialkyl dichlorosuccinate |
| 06/06/2002 | WO2002044153A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 06/06/2002 | WO2002044141A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 06/06/2002 | WO2002044137A1 Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as a medicament, and pharmaceutical preparations containing these compounds |
| 06/06/2002 | WO2002044113A2 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 06/06/2002 | WO2002043667A2 HYDROLYSIS OF [R(R*,R*)]-2-(4-FLUOROPHENYL)-β,δ -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE |
| 06/06/2002 | WO2002043648A2 Compounds active at the glucocorticoid receptor ii |
| 06/06/2002 | WO2002016322A3 Process for the preparation of 2-aminoethylpyridines |
| 06/06/2002 | WO2002007683B1 Antimicotic nail varnish composition |
| 06/06/2002 | US20020068829 Process of preparing 3S-3-amino-3-aryl proprionic acid and derivatives thereof |
| 06/06/2002 | US20020068826 Such as 5-bromo-2-iodopyridine; for production inhibitors in therapy for cytokine-mediated diseases (inflammatory and autoimmune diseases) |
| 06/06/2002 | US20020068765 8,9-dihydro-7H-benzocycloheptene derivatives are useful for phophylaxis and therapy of osteoporosis(have selective estrogenic activity on bones) |
| 06/06/2002 | US20020068758 Novel orally active iron (III) chelators |
| 06/06/2002 | US20020068739 Cholesteryl acyl transferase (ACAT) inhibitors; treatment of hyperlipidaemia and atherosclerosis. |
| 06/06/2002 | US20020066888 Cyclohexane derivatives, liquid crystal compositions comprising the same and liquid crystal display devices |
| 06/06/2002 | US20020066886 Alkenyloxy substituted bi or triaromatic compounds with atleast one benzene ring |
| 06/06/2002 | CA2430354A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 06/06/2002 | CA2430311A1 Compounds active at the glucocorticoid receptor ii |
| 06/06/2002 | CA2430199A1 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 06/06/2002 | CA2427255A1 Hydrolysis of [r(r*,r*)]-2-(4-fluorophenyl)-.beta.,.delta. -dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid esters with calcium hydroxide |
| 06/06/2002 | CA2422729A1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 06/05/2002 | EP1211257A2 Metal coordination compound, luminescence device and display apparatus |
| 06/05/2002 | EP1211240A1 Biscyclopropanecarboxylic acid amide compounds and medicinal use thereof |
| 06/05/2002 | EP1210340A1 Substituted piperazine derivatives, the production thereof and their utilization as medicaments |
| 06/05/2002 | EP1210331A1 Process for the preparation of 2-cyanopyridines |
| 06/05/2002 | EP1003719B1 Microbicidal n-sulfonylglycin alkynyloxyphenemethyl amide derivatives |